Toshiaki Oharaseki Selected Research

mannan receptor

3/2020

Recognition of alpha-mannan by dectin 2 is essential for onset of Kawasaki disease-like murine vasculitis induced by Candida albicans cell-wall polysaccharide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshiaki Oharaseki Research Topics

Disease

10	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 03/2020 - 01/2004
8	Vasculitis (Vasculitides) 05/2022 - 09/2006
8	Arteritis 01/2014 - 01/2004
4	Neoplasms (Cancer) 08/2017 - 11/2009
4	Inflammation (Inflammations) 01/2014 - 09/2011
3	Aneurysm (Aneurysms) 12/2015 - 02/2013
2	Thrombosis (Thrombus) 07/2015 - 02/2010
1	Asthma (Bronchial Asthma) 02/2022
1	Myocarditis (Carditis) 02/2022
1	Spontaneous Rupture 08/2017
1	Shoulder Pain 01/2017
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2017
1	Heart Failure 12/2015
1	Fibrosis (Cirrhosis) 12/2015
1	Prostatic Neoplasms (Prostate Cancer) 06/2015
1	Syphilis 05/2015
1	primary Syphilis 05/2015
1	Disease Susceptibility (Diathesis) 01/2014
1	Necrosis 02/2013
1	Lymphadenopathy 02/2013
1	Fever (Fevers) 01/2012
1	Hyperplasia 05/2011
1	Adenocarcinoma 05/2011
1	Systemic Vasculitis 04/2010
1	Hypersensitivity (Allergy) 02/2010
1	Myocardial Infarction 02/2010
1	Coronary Aneurysm (Aneurysm, Coronary) 02/2010
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 11/2009
1	Margins of Excision 11/2009
1	Anaphylaxis (Anaphylactic Shock) 09/2006
1	Shock 06/2006
1	Fibrosarcoma 08/2004

Drug/Important Bio-Agent (IBA)

7	CytokinesIBA 01/2014 - 01/2004
3	Polysaccharides (Glycans)IBA 03/2020 - 01/2004
3	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2015 - 02/2013
3	ChemokinesIBA 01/2014 - 04/2007
2	Intravenous Immunoglobulins (IVIG)FDA Link 07/2015 - 09/2011
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 05/2022
1	Antigen-Antibody Complex (Immune Complex)IBA 05/2022
1	benralizumabIBA 02/2022
1	GlucansIBA 03/2020
1	mouse dectin-2IBA 03/2020
1	dectin 1IBA 03/2020
1	mannan receptorIBA 03/2020
1	MannansIBA 03/2020
1	TenascinIBA 01/2019
1	CA-125 Antigen (CA 125 Antigen)IBA 08/2017
1	AntigensIBA 08/2017
1	CarbohydratesIBA 08/2017
1	RivaroxabanIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 12/2015
1	Galectin 3 (LGALS3)IBA 12/2015
1	Proteins (Proteins, Gene)FDA Link 12/2015
1	Phenobarbital (Luminal)FDA Link 07/2015
1	Thomsen-Friedenreich antibodiesIBA 05/2015
1	ReaginsIBA 05/2015
1	AntibodiesIBA 05/2015
1	Interleukin-17 (Interleukin 17)IBA 01/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014
1	Infliximab (Remicade)FDA Link 01/2014
1	Etanercept (Enbrel)FDA Link 01/2014
1	Capsules (Microcapsules)IBA 02/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012
1	Blood Proteins (Serum Proteins)IBA 01/2012
1	AngiopoietinsIBA 01/2012
1	Immunoglobulin G (IgG)IBA 09/2011
1	mizoribineIBA 09/2011
1	Immunoglobulins (Immunoglobulin)IBA 04/2010
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2007
1	Pathogen-Associated Molecular Pattern MoleculesIBA 09/2006
1	beta-GlucansIBA 09/2006
1	Biological ProductsIBA 06/2006
1	LigandsIBA 01/2005
1	VimentinIBA 08/2004

Therapy/Procedure

3	Therapeutics 01/2014 - 11/2009
1	Central Venous Catheters 01/2017
1	Endarterectomy (Thromboendarterectomy) 07/2015
1	Punctures 06/2015
1	Prostatectomy (Retropubic Prostatectomy) 06/2015
1	Hysterectomy 05/2011
1	Stents 02/2010
1	Radiotherapy 11/2009
1	Drug Therapy (Chemotherapy) 11/2009
1	Injections 04/2007
1	Intravenous Administration 09/2006
1	Intraperitoneal Injections 01/2005